Debatin, Klaus-Michael 1952-
Debatin, K. M.
Klaus-Michael Debatin
Debatin, Klaus-Michael
Debatin, Klaus-Michael (1951- ).
VIAF ID: 69142538 ( Personal )
Permalink: http://viaf.org/viaf/69142538
Preferred Forms
- 200 _ | ‡a Debatin ‡b Klaus-Michael
-
- 100 1 _ ‡a Debatin, K. M.
-
- 100 1 _ ‡a Debatin, K. M.
-
- 100 1 _ ‡a Debatin, Klaus-Michael
-
-
- 100 1 _ ‡a Debatin, Klaus-Michael ‡d 1952-
- 100 0 _ ‡a Klaus-Michael Debatin
- 100 0 _ ‡a Klaus-Michael Debatin
4xx's: Alternate Name Forms (11)
5xx's: Related Names (4)
- 510 2 _ ‡a Deutsche Akademie der Naturforscher Leopoldina ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 551 _ _ ‡a Heidelberg ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 551 _ _ ‡a Karlsruhe ‡4 ortg ‡4 https://d-nb.info/standards/elementset/gnd#placeOfBirth
- 551 _ _ ‡a Ulm ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
Works
Title | Sources |
---|---|
Apoptosis and cancer therapy from cutting edge science to novel therapeutic concepts | |
Death by design | |
Modulation of apoptosis signaling for cancer therapy | |
mort programmée | |
Natural killer cells generated from human induced pluripotent stem cells mature to CD56brightCD16+NKp80+/-in-vitro and express KIR2DL2/DL3 and KIR3DL1 | |
Pulmonary function and persistent clinical symptoms in children and their parents 12 months after mild SARS-CoV-2 infection | |
Role of ABO blood group in SARS-CoV-2 infection in households | |
Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection | |
Therapeutic approaches to pediatric COVID-19: an online survey of pediatric rheumatologists | |
The Thymus, c1992: | |
Thymus Diagnostic Imaging, Functions, and Pathologic Anatomy | |
Untersuchungen über die Freisetzung lysosomaler Enzyme aus Neutrophilen Granulozyten bei der Bakterienphagozytose | |
Vaccination rate and immunity of children and adolescents with inflammatory bowel disease or autoimmune hepatitis in Germany | |
Wachstumskontrolle normaler und maligner Lymphozyten | |
Zukunftsfragen für die Forschung in der Kinder- und Jugendmedizin in Deutschland |